Who Paid My Doc
Prolaris
Device Oncology
General payments
$665,441
Research payments
$430,184
Through program year 2025, $665,441 in general payments and $430,184 in research payments were reported against Prolaris (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $62,174 | 2,536 |
| 2025 | Research | $110,841 | 17 |
| 2024 | General | $218,391 | 5,789 |
| 2024 | Research | $4,964 | 5 |
| 2023 | General | $384,877 | 7,866 |
| 2023 | Research | $314,379 | 26 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 49 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
16,191 general · 48 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.